Dr. Moghadam-Kia’s academic interests are inflammatory myopathies, biomarker clinical studies, cutaneous manifestations of systemic rheumatic disease, connective tissue disease-associated interstitial lung disease (CTD-ILD), rheumatoid arthritis, spondyloarthritis, teaching and training rheumatology fellows and medicine residents.
- M.D., Tehran University of Medical Sciences, 2003
- M.P.H., University of Pittsburgh, 2015
- Residency: Internal Medicine, Georgetown University Hospital/Washington Hospital Center, 2012
- Fellowship: Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, 2014
Education & Training
Moghadam-Kia, S., Oddis, C.V. Myositis-Associated Interstitial Lung Disease. Revista Colombiana de Reumatología (English Edition). 2023; In press
Saygin, D., Biswas, P., Nouraie, S., Ren, D., Moghadam-Kia, S., McGeachy, M., Oddis, C., Dzanko, S., Koontz, D., Ascherman, D., Aggarwal, R. Serum Cytokine Profiles of Patients with Adult Idiopathic Inflammatory Myopathies. Clinexprheumatol (In Press). 2023
Sen, P., Naveen, R., Houshmand, N., Moghadam-Kia, S., Joshi, S., Saha, S., Jagtap, K., Agarwal, V., Nune, A., Nikiphorou, E., Tan, A.L., Shinjo, S.K., Ziade, N., Velikova, T., Milchert, M., Parodis, I., Edgar Gracia-Ramos, A., Cavagna, L., et al. Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys. Rheumatology (Oxford). 2023 Feb 3:kead057. doi: 10.1093/rheumatology/kead057. PMID: 36734536. 2023; Epub ahead of print.
Yamaguchi, K., Poland, P., George, T.B., Saygin, D., Moghadam-Kia, S., Aggarwal, R., Oddis, C.V., Zhu, L., Ascherman, D.P. Correlation between B cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). Oct 10:kead550. doi: 10.1093/rheumatology/kead550. 2023; Epub ahead of print. PMID: 37815819
Adeghate, J., Bonhomme, G., Indermill, C., Taylor, S., Rocha, M., Moghadam-Kia, S., Errera, M. Retinal neovascularization in Susac’s syndrome: A rare imaging finding. Oman J Ophthalmol (In Press). 2023
Oldroyd, AGS., Callen, J.P., Chinoy, H., Chung, L., Fiorentino, D., Gordon, P., Machado, P.M., McHugh, N., Selva-O'Callaghan, A., Schmidt, J., Tansley, S.L., Vleugels, R.A., Werth, V.P., Moghadam-Kia, S. International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol. 2023; 12: 805-817.
Oddis, C.V., Rockette, H.E., Zhu, L., Koontz, D.C., Lacomis, D., Venturupalli, S., Moghadam-Kia, S., Ascherman, D.P., Crofford, L., Dimachkie, M.M., Ernste, F., Gazeley, D., Marder, G., Aggarwal, R. Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis. ACR Open Rheumatol. PMID: 36128663. 2022; 4 (11): 983-990.
Hosono, Y., Sie, B., Pinal-Fernandez, I., Pak, K., Mecoli, C.A., Casal-Dominquez, M., Warner, B.M., Kaplan, M.J., Albayda, J., Danoff, S., Lloyd, T.E., Paik, J.J., Tiniakou, E., Aggarwal, R., Oddis, C.V., Moghadam-Kia, S., Carmona-Rivera, C., et al. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1? autoantibodies. Ann Rheum Dis. PMID: 36008132. 2023; Feb;82(2): 246-252.
Moghadam-Kia, S., Oddis, C.V. Current and new targets for treating myositis. Curr Opin Pharmacol.PMID: 35724455. 2022; Aug;65:1022557
- Japan College of Rheumatology Award, 2015
- Certificate of achievement for top oral presentation, Congress of Clinical Rheumatology Meeting, Destin, Florida, 2015
- American College of Rheumatology Distinguished Fellow Award, 2014
- Honorable mention-American College of Rheumatology Annual Image Competition, 2013
- Caplan Research Award, University of Pittsburgh Arthritis Center, 2012-2013
- Best Poster Award, American College of Physicians D.C. Chapter Annual Meeting, DC, 2010
